Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer.
about
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 geneH19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expressionP53 autoantibodies in 1006 patients followed up for breast cancer.A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteinsImmunologic aspect of ovarian cancer and p53 as tumor antigen.Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancerPyridoxal phosphatase is a novel cancer autoantigen in the central nervous system.Molecular technology and pancreatic cancer.Detection of serum anti-p53 antibodies from patients with ovarian cancer in China: correlation to clinical parameters.Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patientsIdentification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer.Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokersExpression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epitheliaDetection and monitoring of serum p53 antibodies in patients with colorectal cancer.Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cellsPermanent expression of p53 in FR 3T3 rat cells but cell cycle-dependent association with large-T antigen in simian virus 40 transformants.Monoclonal antibodies displaying a novel species specificity for the primate transformation-related protein, p53.The history of p53. A perfect example of the drawbacks of scientific paradigms.Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.Autoantibodies to tumor-associated antigens in breast carcinoma.Clinical validation of an autoantibody test for lung cancer.Biomarkers of gene expression: growth factors and oncoproteins.Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemia.Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts.A question of transformation: the synovial fibroblast in rheumatoid arthritisRelative paradigms between autoantibodies in lupus and autoantibodies in cancer.Oncogenes and tumor suppressor genes: new biochemical tests.Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseasesEvaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.Serum anti-p53 antibody as a tumour marker for colorectal cancer screeningAnalyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.The relationship between serum p53 autoantibodies and characteristics of human breast cancer.The tumor suppressor gene TP53: implications for cancer management and therapy.Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.Absence of p53 autoantibodies in a significant proportion of breast cancer patients.Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumorsDo heat shock proteins have a role in breast cancer?Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients.
P2860
Q24555633-40401A38-CFE1-407B-B20A-2F73767C58F2Q24682023-295BFBEE-BC46-49E1-A6E2-CC3400D79558Q24791426-4329CE00-0F05-4D31-87F7-6D87229C9029Q24813048-4C87BB6A-AC08-40DC-A7B8-1DDDDEB686C1Q24814703-3CC4D2F0-FBA9-4780-88E1-7AB5674C3C33Q27002356-F9E29600-162E-4D3D-A214-594ECFC37E68Q31116916-98A4057E-D921-4C64-A3F7-3B7543FEC922Q31800438-C08A11B0-1D4D-4C22-A5C8-76204B157429Q33303413-86780DD9-47A4-4455-898E-31333B4F50C2Q33320360-F062EF2A-3BF8-4342-8FF7-4E2565C4D669Q33432974-1508AFE0-BBB6-40E9-92B7-B22115B738F2Q33588113-0B997F94-D03F-47C0-9D4D-A471C416CAE5Q33613015-0DED3E4E-00D6-408B-B6CB-98BDE10322B1Q33617886-57BCE7CF-56BD-4EF4-874C-FDDC8E8ED257Q33927506-0230FCCC-BE4D-4EDD-A72F-E04D71BA0421Q33932090-B342FE0A-A5A7-47CC-A0C6-8EF584F526B4Q33933776-2FD0C9B7-0EAB-443F-84DC-BDB43B732DACQ34142403-DCCB8097-6C4E-4F7F-90C2-1E9D4E23D7C6Q34219323-5D355BCA-51DF-4873-B2EE-A0AD6FD439E7Q34339160-562AB39E-CD9B-4407-AE56-C37CC7BAA618Q34537374-3646BA2F-5ED2-424E-8F00-1E2DAB9F42DDQ34638885-B94B43F4-CECA-49FB-9973-3F7C9647A647Q35049753-B6ED57DF-1929-44E8-996F-E281B6CE3882Q35059164-1F4C1273-DBE9-4E34-AFF9-FF2422D14289Q35066912-D5F627F8-C1C7-4E1A-9A04-9BA98C83AC19Q35111655-8A8F9EC2-E096-4453-A9BC-86861E331DF3Q35583352-3434E822-1A90-4D8C-80EF-5EADAC0A0AEEQ35662775-FB28FBE5-BD49-4F38-89AE-022677C6AE33Q35821185-2E5CB1F0-9C80-45C3-BAF2-1692DA68A9EFQ35840714-C34BCBC8-3AB0-479D-8589-FCE3CBA2B229Q35935368-225B6FFD-C68B-458C-8481-38EDF8BB9758Q35978507-1D6F7602-D2C7-4776-8356-176A9FB40976Q35979208-4A43FFE4-44A3-466D-84FD-2F8BA56135BBQ35986418-7A0F4A3B-4E92-474A-A4CF-EBE809FBECECQ36080258-51EEE984-27E1-42A3-B6F6-1C9603F6621CQ36081057-F572E969-A710-4549-8731-FE766830F18AQ36110472-E941EDA0-7FC3-4D2B-9079-7998618A4431Q36136058-B888436E-D5EC-4A68-8D71-918D55D64533Q36169087-E18A79F4-5FE3-4A01-AEF6-BC50ADCBBDFAQ36244272-736518ED-56F8-44CD-A4FC-ACB5F3C49744
P2860
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Detection of antibodies agains ...... m patients with breast cancer.
@en
Detection of antibodies agains ...... m patients with breast cancer.
@nl
type
label
Detection of antibodies agains ...... m patients with breast cancer.
@en
Detection of antibodies agains ...... m patients with breast cancer.
@nl
prefLabel
Detection of antibodies agains ...... m patients with breast cancer.
@en
Detection of antibodies agains ...... m patients with breast cancer.
@nl
P2093
P356
P1476
Detection of antibodies agains ...... m patients with breast cancer.
@en
P2093
L V Crawford
R D Bulbrook
P304
P356
10.1002/IJC.2910300404
P577
1982-10-01T00:00:00Z